MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,943 | -45.3% | 68,082 | -13.5% | 0.02% | -34.6% |
Q2 2023 | $18,176 | -57.2% | 78,682 | -55.1% | 0.03% | -53.6% |
Q1 2023 | $42,488 | +3094.6% | 175,382 | +3727.6% | 0.06% | +2700.0% |
Q4 2022 | $1,330 | -99.7% | 4,582 | -4.5% | 0.00% | +100.0% |
Q1 2022 | $471,000 | +132.0% | 4,800 | +100.0% | 0.00% | – |
Q4 2021 | $203,000 | -85.1% | 2,400 | -86.0% | 0.00% | -100.0% |
Q3 2021 | $1,365,000 | -73.6% | 17,111 | -67.7% | 0.00% | -66.7% |
Q2 2021 | $5,161,000 | +28.7% | 52,982 | +54.5% | 0.01% | +20.0% |
Q1 2021 | $4,010,000 | +6.0% | 34,282 | +0.7% | 0.01% | +25.0% |
Q4 2020 | $3,783,000 | +46.3% | 34,033 | +56.2% | 0.00% | +33.3% |
Q3 2020 | $2,586,000 | -68.5% | 21,782 | -69.9% | 0.00% | -57.1% |
Q2 2020 | $8,197,000 | +363.6% | 72,382 | +173.3% | 0.01% | +250.0% |
Q1 2020 | $1,768,000 | -78.0% | 26,482 | -69.8% | 0.00% | -77.8% |
Q4 2017 | $8,040,000 | +40.4% | 87,587 | -31.2% | 0.01% | +28.6% |
Q3 2017 | $5,725,000 | +367.0% | 127,287 | +68.8% | 0.01% | +250.0% |
Q2 2017 | $1,226,000 | +37.6% | 75,387 | +30.3% | 0.00% | +100.0% |
Q1 2017 | $891,000 | +4.1% | 57,875 | +0.7% | 0.00% | 0.0% |
Q4 2016 | $856,000 | +27.4% | 57,475 | +8.5% | 0.00% | 0.0% |
Q3 2016 | $672,000 | – | 52,987 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |